Breaking News Instant updates and real-time market news.

SNY

Sanofi

$49.79

0.24 (0.48%)

, REGN

Regeneron

$435.43

0.46 (0.11%)

05:36
09/28/17
09/28
05:36
09/28/17
05:36

Sanofi, Regeneron announce approval of Dupixent in EU

Sanofi (SNY) and Regeneron (REGN) announced that the European Commission has granted marketing authorization for Dupixent, for use in adults with moderate-to-severe atopic dermatitis, or AD, who are candidates for systemic therapy. Dupixent is approved in the U.S. for the treatment of adults with moderate-to-severe atopic dermatitis that is not well controlled with prescription therapies used on the skin, or who cannot use topical therapies. Dupixent can be used with or without topical corticosteroids. It is not known if Dupixent is safe and effective in children.

SNY

Sanofi

$49.79

0.24 (0.48%)

REGN

Regeneron

$435.43

0.46 (0.11%)

  • 18

    Oct

SNY Sanofi
$49.79

0.24 (0.48%)

07/31/17
ADAM
07/31/17
NO CHANGE
Target $522
ADAM
Buy
Dupixent authorization approval rate outweighs Q2 miss, says Canaccord
Regeneron (REGN) partner Sanofi (SNY) reported a "very high" 73%-83% prior authorization approval rate for Dupixent in Q2, which Canaccord analyst John Newman said outweighs the fact that sales for the drug at $30.6M were slightly below the $33M consensus forecast. The analyst, who sees rapid payor acceptance of Dupixent as "much more crucial" than the initial quarterly revenue, keeps a Buy rating and $522 price target on Regeneron shares.
08/30/17
HSBC
08/30/17
UPGRADE
Target $81
HSBC
Hold
Sanofi upgraded to Hold from Reduce at HSBC
HSBC analyst Steve McGarry upgraded Sanofi to Hold and increased its price target to $81 from $79 citing valuation and said he sees few catalysts to own the shares either.
08/30/17
08/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sanofi (SNY) upgraded to Hold from Reduce at HSBC, with analyst Steve McGarry citing valuation. 2. M.D.C. Holdings (MDC) upgraded to Market Perform from Underperform at Wells Fargo with analyst Stephen East saying he sees "little reason the equity would move meaningfully lower" from current levels. 3. Ciena (CIEN) upgraded to Buy from Neutral at Citi with analyst Stanley Kovler saying the risk/reward is positive into third quarter results. 4. Six Flags (SIX) upgraded to Buy from Neutral at Hilliard Lyons with analyst Jeff Thomison citing improved valuation based on its 13% year-to-date pullback. 5. Prospect Capital (PSEC) upgraded to Market Perform from Underperform at Raymond James with analyst Robert Dodd saying he expects near-term earnings will cover the lower dividend run-rate but notes downside risk remains. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
FBCO
09/11/17
NO CHANGE
Target $485
FBCO
Outperform
Regeneron, Sanofi asthma trial 'statistically significant,' says Credit Suisse
Credit Suisse analyst Alethia Young notes that Regeneron (REGN)/Sanofi (SNY) released top-line asthma results, and the overall trial was "statistically significant." Specifically, the trial hit in the overall population, but it is unclear if the trial was statistically significant in the low eosinophil level patients alone, she notes. The analyst reiterates an Outperform rating and $485 price target on Regeneron's shares.
REGN Regeneron
$435.43

0.46 (0.11%)

09/11/17
PIPR
09/11/17
NO CHANGE
Target $557
PIPR
Overweight
Regeneron pullback today a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using today's weakness in shares of Regeneron Pharmaceuticals as a buying opportunity. The analyst calls the Phase III Quest data in severe asthma patients positive and projects peak U.S. asthma sales of $2.2B by 2025. He reiterates an Overweight rating on Regeneron with a $557 price target. The stock in early trading is down 6% to $443.39.
09/14/17
RBCM
09/14/17
INITIATION
Target $475
RBCM
Sector Perform
Regeneron initiated with a Sector Perform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Regeneron with a Sector Perform and a $475 price target.
09/21/17
UBSW
09/21/17
NO CHANGE
Target $500
UBSW
Buy
Regeneron price target lowered to $500 from $535 at UBS
UBS analyst Carter Gould lowered his price target on Regeneron (REGN) to $500 from $535 citing increased Dupixent competition after Amgen (AMGN) and AstraZeneca (AZN) reported data on their own asthma drug earlier this month and AbbVie (ABBV) reported results in an atopic dermatitis study. While he noted that definitive 12-month phase 3 data from these competitors is likely more than 20 months away, he also lowered his Dupixent peak sales estimate to $4.8B from $6.5B. He keeps a Buy rating on Regeneron shares, as he believes pipeline products including nesvacumab and REGN2810 offer a path to longer-term upside.

TODAY'S FREE FLY STORIES

SAGE

Sage Therapeutics

$61.43

0.08 (0.13%)

14:51
10/17/17
10/17
14:51
10/17/17
14:51
Conference/Events
Sage Therapeutics management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

S

Sprint

$7.10

-0.05 (-0.70%)

14:50
10/17/17
10/17
14:50
10/17/17
14:50
Options
$7M put buyer in Sprint »

$7M put buyer in Sprint.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 16

    May

IBM

IBM

$146.51

-0.32 (-0.22%)

14:49
10/17/17
10/17
14:49
10/17/17
14:49
Options
IBM options imply 5.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

STZ

Constellation Brands, also tag STZ.B

$212.29

1.84 (0.87%)

14:46
10/17/17
10/17
14:46
10/17/17
14:46
Conference/Events
Constellation Brands, also tag STZ.B management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SVU

Supervalu

$18.90

0.085 (0.45%)

14:40
10/17/17
10/17
14:40
10/17/17
14:40
Options
Short-term call buying in SuperValu as shares slip into earnings »

Short-term call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

HES

Hess Corp.

$45.67

-0.37 (-0.80%)

14:30
10/17/17
10/17
14:30
10/17/17
14:30
Options
Hefty spread in Hess as a bullish position is adjusted »

Hefty spread in Hess as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

DAL

Delta Air Lines

$52.91

-0.71 (-1.32%)

, MSG

Madison Square Garden

$215.84

-1.91 (-0.88%)

14:27
10/17/17
10/17
14:27
10/17/17
14:27
Hot Stocks
Delta expands MSG, MSG Networks partnership »

Delta (DAL) has renewed…

DAL

Delta Air Lines

$52.91

-0.71 (-1.32%)

MSG

Madison Square Garden

$215.84

-1.91 (-0.88%)

MSGN

MSG Networks

$21.03

0.275 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MOH

Molina Healthcare

$61.64

1.78 (2.97%)

, UNH

UnitedHealth

$205.36

12.16 (6.29%)

14:27
10/17/17
10/17
14:27
10/17/17
14:27
Periodicals
Senator says bipartisan deal reached to stabilize ObamaCare, The Hill reports »

Republican Senator Lamar…

MOH

Molina Healthcare

$61.64

1.78 (2.97%)

UNH

UnitedHealth

$205.36

12.16 (6.29%)

CNC

Centene

$93.61

2.6901 (2.96%)

WCG

WellCare

$173.81

5.89 (3.51%)

CI

Cigna

$188.26

3.27 (1.77%)

ANTM

Anthem

$189.00

5.24 (2.85%)

HNT

Health Net

HUM

Humana

$241.96

4.785 (2.02%)

AET

Aetna

$155.62

4.18 (2.76%)

THC

Tenet

$13.31

0.4 (3.10%)

UHS

Universal Health

$108.19

2.59 (2.45%)

LPNT

LifePoint

$55.80

0.8 (1.45%)

HCA

HCA Healthcare

$77.14

1.95 (2.59%)

CYH

Community Health

$6.13

0.23 (3.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Oct

  • 25

    Oct

  • 31

    Oct

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

14:25
10/17/17
10/17
14:25
10/17/17
14:25
General news
Fed discount rate meeting minutes: 11 of 12 Banks voted for an unchanged »

Fed discount rate meeting…

ORI

Old Republic

$19.53

-0.24 (-1.21%)

14:21
10/17/17
10/17
14:21
10/17/17
14:21
Hot Stocks
Breaking Hot Stocks news story on Old Republic »

Old Republic trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTN

Vail Resorts

$218.22

1.7975 (0.83%)

14:20
10/17/17
10/17
14:20
10/17/17
14:20
Options
Call buyers in Vail Resorts as shares see strength »

Call buyers in Vail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

SVU

Supervalu

$18.77

-0.04 (-0.21%)

14:18
10/17/17
10/17
14:18
10/17/17
14:18
Technical Analysis
Technical Earnings Preview: Supervalu at multi-year lows ahead of results »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

14:17
10/17/17
10/17
14:17
10/17/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$39.76

0.09 (0.23%)

, NVDA

Nvidia

$197.93

3.34 (1.72%)

14:16
10/17/17
10/17
14:16
10/17/17
14:16
Periodicals
Intel unveils new family of chips to take on Nvidia in AI, The Verge says »

Intel (INTC) has unveiled…

INTC

Intel

$39.76

0.09 (0.23%)

NVDA

Nvidia

$197.93

3.34 (1.72%)

SFTBF

SoftBank

$89.80

0.9 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 01

    Nov

$NYE

NYSE Market Internals

14:16
10/17/17
10/17
14:16
10/17/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORI

Old Republic

$19.53

-0.245 (-1.24%)

14:11
10/17/17
10/17
14:11
10/17/17
14:11
Hot Stocks
Old Republic says Q3 to include operating charges of $150M »

Old Republic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$11.73

0.11 (0.95%)

14:10
10/17/17
10/17
14:10
10/17/17
14:10
Options
Call buyers in Navient ahead of earnings »

Call buyers in Navient…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

UNP

Union Pacific

$110.09

-2 (-1.78%)

14:08
10/17/17
10/17
14:08
10/17/17
14:08
Periodicals
Breaking Periodicals news story on Union Pacific »

Union Pacific initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

PACW

PacWest Bancorp

$48.09

0.13 (0.27%)

14:05
10/17/17
10/17
14:05
10/17/17
14:05
Downgrade
PacWest Bancorp rating change  »

PacWest Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 09

    Nov

  • 13

    Nov

  • 14

    Nov

MOH

Molina Healthcare

$60.74

0.88 (1.47%)

, UNH

UnitedHealth

$204.93

11.73 (6.07%)

14:01
10/17/17
10/17
14:01
10/17/17
14:01
Periodicals
Senator Alexander says deal reached to shore up ACA markets, Bloomberg says »

Bloomberg cites Senator…

MOH

Molina Healthcare

$60.74

0.88 (1.47%)

UNH

UnitedHealth

$204.93

11.73 (6.07%)

CNC

Centene

$92.84

1.92 (2.11%)

WCG

WellCare

$172.72

4.8 (2.86%)

CI

Cigna

$187.49

2.5 (1.35%)

ANTM

Anthem

$187.60

3.8392 (2.09%)

HNT

Health Net

HUM

Humana

$241.08

3.905 (1.65%)

AET

Aetna

$155.17

3.7303 (2.46%)

HCA

HCA Healthcare

$75.63

0.44 (0.59%)

CYH

Community Health

$5.97

0.065 (1.10%)

THC

Tenet

$12.79

-0.12 (-0.93%)

UHS

Universal Health

$106.78

1.18 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Oct

  • 25

    Oct

  • 31

    Oct

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

ORI

Old Republic

$19.54

-0.23 (-1.16%)

14:01
10/17/17
10/17
14:01
10/17/17
14:01
Hot Stocks
Breaking Hot Stocks news story on Old Republic »

Old Republic trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$128.76

1.035 (0.81%)

14:00
10/17/17
10/17
14:00
10/17/17
14:00
Hot Stocks
Deere wins trademark lawsuit against FIMCO »

U.S. District Court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

XLF

Financial Select Sector

$26.13

-0.17 (-0.65%)

14:00
10/17/17
10/17
14:00
10/17/17
14:00
Options
Whale of a trade in SPDR Financial ETF expresses a defensive view »

Whale of a trade in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

13:47
10/17/17
10/17
13:47
10/17/17
13:47
Periodicals
Amazon inks deals with apartment landlords for lockers, WSJ reports »

Amazon.com has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

WMT

Wal-Mart

$85.81

0.065 (0.08%)

13:41
10/17/17
10/17
13:41
10/17/17
13:41
Periodicals
Wal-Mart's Lore: Company plans to acquire more startups, TechCrunch reports »

Wal-Mart eCommerce CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.